Newron Pharmaceuticals S.p.A. historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-03-18 | 7.724 | 7.724 | 7.724 | 7.724 | 7.724 | 422 |
| 2024-03-15 | 8.033 | 8.033 | 7.820 | 8.020 | 8.020 | 11,136 |
| 2024-03-14 | 7.831 | 7.831 | 7.760 | 7.760 | 7.760 | 2,479 |
| 2024-03-13 | 7.754 | 7.860 | 7.653 | 7.827 | 7.827 | 5,206 |
| 2024-03-12 | 8.191 | 8.191 | 8.164 | 8.164 | 8.164 | 7,749 |
| 2024-03-11 | 8.380 | 8.411 | 8.137 | 8.137 | 8.137 | 2,375 |
| 2024-03-08 | 7.660 | 7.660 | 7.660 | 7.660 | 7.660 | 28 |
| 2024-03-07 | 7.680 | 7.680 | 7.680 | 7.680 | 7.680 | 101 |
| 2024-03-06 | 7.791 | 7.840 | 7.791 | 7.840 | 7.840 | 713 |
| 2024-03-05 | 7.940 | 7.943 | 7.900 | 7.943 | 7.943 | 5,966 |
| 2024-03-04 | 8.180 | 8.226 | 8.180 | 8.226 | 8.226 | 3,524 |
| 2024-03-01 | 8.200 | 8.380 | 8.200 | 8.380 | 8.380 | 2,367 |
| 2024-02-29 | 8.200 | 8.200 | 8.200 | 8.200 | 8.200 | 26 |
| 2024-02-28 | 8.300 | 8.460 | 8.300 | 8.460 | 8.460 | 2,564 |
| 2024-02-27 | 8.600 | 8.600 | 8.515 | 8.580 | 8.580 | 1,351 |
| 2024-02-26 | 8.687 | 8.687 | 8.600 | 8.600 | 8.600 | 7,354 |
| 2024-02-23 | 8.180 | 8.180 | 8.180 | 8.180 | 8.180 | 0 |
| 2024-02-22 | 8.180 | 8.180 | 8.180 | 8.180 | 8.180 | 500 |
| 2024-02-21 | 8.420 | 8.420 | 8.420 | 8.420 | 8.420 | 0 |
| 2024-02-20 | 8.420 | 8.420 | 8.420 | 8.420 | 8.420 | 0 |
| 2024-02-19 | 8.300 | 8.420 | 8.300 | 8.420 | 8.420 | 253 |
| 2024-02-16 | 8.300 | 8.373 | 8.160 | 8.373 | 8.373 | 1,085 |
| 2024-02-15 | 8.400 | 8.400 | 8.280 | 8.320 | 8.320 | 1,193 |
| 2024-02-14 | 8.680 | 8.680 | 8.680 | 8.680 | 8.680 | 1,705 |
| 2024-02-13 | 8.741 | 8.741 | 8.741 | 8.741 | 8.741 | 4,603 |
| 2024-02-12 | 8.960 | 8.960 | 8.813 | 8.813 | 8.813 | 1,225 |
| 2024-02-09 | 8.740 | 8.740 | 8.740 | 8.740 | 8.740 | 0 |
| 2024-02-08 | 8.740 | 8.740 | 8.740 | 8.740 | 8.740 | 150 |
| 2024-02-07 | 8.580 | 8.970 | 8.580 | 8.664 | 8.664 | 5,826 |
| 2024-02-06 | 9.113 | 9.113 | 8.680 | 8.680 | 8.680 | 5,779 |
| 2024-02-05 | 7.820 | 7.820 | 7.820 | 7.820 | 7.820 | 108 |
| 2024-02-02 | 7.703 | 7.703 | 7.670 | 7.670 | 7.670 | 3,626 |
| 2024-02-01 | 7.760 | 7.760 | 7.700 | 7.700 | 7.700 | 581 |
| 2024-01-31 | 7.740 | 7.740 | 7.700 | 7.720 | 7.720 | 2,270 |
| 2024-01-30 | 8.060 | 8.060 | 7.940 | 8.032 | 8.032 | 10,729 |
| 2024-01-29 | 8.160 | 8.196 | 8.160 | 8.196 | 8.196 | 1,185 |
| 2024-01-26 | 8.260 | 8.260 | 8.025 | 8.025 | 8.025 | 725 |
| 2024-01-25 | 7.640 | 7.905 | 7.640 | 7.700 | 7.700 | 7,381 |
| 2024-01-24 | 8.197 | 8.300 | 8.197 | 8.300 | 8.300 | 281 |
| 2024-01-23 | 7.800 | 7.800 | 7.640 | 7.640 | 7.640 | 247 |
| 2024-01-22 | 7.840 | 7.890 | 7.778 | 7.778 | 7.778 | 1,998 |
| 2024-01-19 | 7.620 | 7.752 | 7.280 | 7.752 | 7.752 | 7,480 |
| 2024-01-18 | 8.325 | 8.436 | 8.325 | 8.436 | 8.436 | 15,445 |
| 2024-01-17 | 9.000 | 9.259 | 8.200 | 8.554 | 8.554 | 15,032 |
| 2024-01-16 | 10.050 | 10.155 | 10.050 | 10.155 | 10.155 | 7,173 |
| 2024-01-15 | 10.400 | 10.400 | 10.118 | 10.368 | 10.368 | 31,000 |
| 2024-01-12 | 8.820 | 8.820 | 8.815 | 8.815 | 8.815 | 2,338 |
| 2024-01-11 | 8.860 | 8.940 | 8.346 | 8.489 | 8.489 | 9,611 |
| 2024-01-10 | 7.980 | 8.000 | 7.220 | 7.220 | 7.220 | 7,402 |
| 2024-01-09 | 7.200 | 7.200 | 6.838 | 7.180 | 7.180 | 7,649 |
| 2024-01-08 | 6.295 | 6.295 | 6.295 | 6.295 | 6.295 | 0 |
| 2024-01-05 | 5.840 | 6.295 | 5.840 | 6.295 | 6.295 | 3,327 |
| 2024-01-04 | 6.140 | 6.140 | 5.526 | 5.526 | 5.526 | 9,637 |
| 2024-01-03 | 4.833 | 4.833 | 4.833 | 4.833 | 4.833 | 1,533 |
| 2024-01-02 | 4.971 | 4.971 | 4.971 | 4.971 | 4.971 | 0 |
| 2023-12-29 | 4.950 | 4.971 | 4.950 | 4.971 | 4.971 | 4,415 |
| 2023-12-28 | 5.020 | 5.190 | 5.020 | 5.190 | 5.190 | 7,408 |
| 2023-12-27 | 4.700 | 4.700 | 4.700 | 4.700 | 4.700 | 1,775 |
| 2023-12-22 | 4.289 | 4.430 | 4.289 | 4.430 | 4.430 | 2,340 |
| 2023-12-21 | 4.390 | 4.400 | 4.390 | 4.400 | 4.400 | 564 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (GBP). Adjusted close accounts for splits and dividends. Educational only, not financial advice.